Literature DB >> 18611361

Optimal treatment of the diabetic patient with multivessel disease.

Sameer Bansilal1, Michael E Farkouh, Valentin Fuster.   

Abstract

Diabetes is emerging as a major source of cardiovascular morbidity and mortality. The atherosclerosis associated with diabetes has a complex etiology with even more complicated manifestations, such as multivessel and diffuse coronary disease. The optimal management of the diabetic patient with multivessel disease poses a special challenge in terms of the selection of the revascularization strategy and medical therapies. In this article, we assess the evidence accumulated to date and discuss ongoing studies that will help better inform this intricate decision-making process.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18611361     DOI: 10.1007/s11886-008-0045-x

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  56 in total

1.  Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial.

Authors:  Patrick W Serruys; Andrew T L Ong; Lex A van Herwerden; J Eduardo Sousa; Adib Jatene; Johannes J R M Bonnier; Jacques P M A Schönberger; Nigel Buller; Robert Bonser; Clemens Disco; Bianca Backx; Paul G Hugenholtz; Brian G Firth; Felix Unger
Journal:  J Am Coll Cardiol       Date:  2005-08-16       Impact factor: 24.094

2.  Standards of medical care in diabetes--2007.

Authors: 
Journal:  Diabetes Care       Date:  2007-01       Impact factor: 19.112

3.  Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention.

Authors:  K M Anderson; R M Califf; G W Stone; F J Neumann; G Montalescot; D P Miller; J J Ferguson; J T Willerson; H F Weisman; E J Topol
Journal:  J Am Coll Cardiol       Date:  2001-06-15       Impact factor: 24.094

Review 4.  Drug eluting stents: an updated meta-analysis of randomised controlled trials.

Authors:  C Roiron; P Sanchez; A Bouzamondo; P Lechat; G Montalescot
Journal:  Heart       Date:  2005-10-10       Impact factor: 5.994

5.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

6.  Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty.

Authors:  G W Barsness; E D Peterson; E M Ohman; C L Nelson; E R DeLong; J G Reves; P K Smith; R D Anderson; R H Jones; D B Mark; R M Califf
Journal:  Circulation       Date:  1997-10-21       Impact factor: 29.690

7.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

8.  Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

Authors:  Helen M Colhoun; D John Betteridge; Paul N Durrington; Graham A Hitman; H Andrew W Neil; Shona J Livingstone; Margaret J Thomason; Michael I Mackness; Valentine Charlton-Menys; John H Fuller
Journal:  Lancet       Date:  2004 Aug 21-27       Impact factor: 79.321

9.  Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes.

Authors:  Donna H Ryan; Mark A Espeland; Gary D Foster; Steven M Haffner; Van S Hubbard; Karen C Johnson; Steven E Kahn; William C Knowler; Susan Z Yanovski
Journal:  Control Clin Trials       Date:  2003-10

10.  Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 years. Analysis of 229 diabetic patients with and without clinical evidence of coronary heart disease and comparison to 183 control subjects.

Authors:  B F Waller; P J Palumbo; J T Lie; W C Roberts
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

View more
  1 in total

1.  The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entry.

Authors:  Sameer Bansilal; Michael E Farkouh; Whady Hueb; May Ogdie; George Dangas; Alexandra J Lansky; David J Cohen; Elizabeth A Magnuson; Krishnan Ramanathan; Jean-Francois Tanguay; Victoria Muratov; Lynn A Sleeper; Michael Domanski; Michel E Bertrand; Valentin Fuster
Journal:  Am Heart J       Date:  2012-10       Impact factor: 4.749

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.